These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38813056)

  • 1. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
    Suda T
    World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
    Zheng BH; Ni XJ; Liu HB
    World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
    Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
    World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
    Li C; Xu X
    Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of exosomal circular RNAs as microRNA sponges and potential targeting for suppressing hepatocellular carcinoma growth and progression.
    Papadopoulos N; Trifylli EM
    World J Gastroenterol; 2024 Mar; 30(9):994-998. PubMed ID: 38577187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
    Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
    J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of exosomes in the development and treatment of hepatocellular carcinoma.
    Li X; Li C; Zhang L; Wu M; Cao K; Jiang F; Chen D; Li N; Li W
    Mol Cancer; 2020 Jan; 19(1):1. PubMed ID: 31901224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
    Sorop A; Constantinescu D; Cojocaru F; Dinischiotu A; Cucu D; Dima SO
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.
    Wang H; Lu Z; Zhao X
    J Hematol Oncol; 2019 Dec; 12(1):133. PubMed ID: 31815633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
    He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
    Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
    Wu MN; Sun JY; Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exosomal proteomics study in the tumorigenesis, development and treatment of hepatocellular carcinoma].
    Zhao L; Xu F; Zhang Y; Xu P
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1992-2000. PubMed ID: 33169565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 17. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
    Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
    Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
    Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
    Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma.
    Sun W; Fu S; Wu S; Tu R
    Biomed Res Int; 2020; 2020():4501454. PubMed ID: 33313314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.